Form 8-K · Current report
News Corp 8-K, filed Oct 9, 2026
- Filed
- CIK
- 0001564708
- Accession no.
- 0001564708-26-000219
Summary
News Corp reported buying back 62,323 shares of its Class A common stock for about US$1.80 million on October 8, 2026 under its 2025 Repurchase Program, which authorizes up to US$1 billion of Class A and Class B buybacks; roughly US$522.7 million had been spent under the program as of that date. The company said the repurchases are intended to enhance shareholder value.
Key points
- Cumulative buybacks before the previous day totaled 12,982,941 shares for US$341,251,595.07 under the 2025 Repurchase Program.
- On the previous day, the highest price paid per share was US$29.15 and the lowest was US$28.52.
- The Class A common stock class had 358,831,617 shares on issue.
- The 2025 Repurchase Program was authorized as of July 15, 2025 for up to an aggregate US$1 billion of Nasdaq-listed Class A and Class B common stock.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 8.01Other Events
- 9.01Financial Statements and Exhibits
From the filing
Item 8.01 Other Events. As previously reported, under News Corporation's (the "Company's") stock repurchase program (the "Repurchase Program"), the Company is authorized to acquire from time to time up to $1 billion in the aggregate of the Company's outstanding shares of Class A common stock and Class B common stock. Under the rules of the Australian Securities Exchange (the "ASX"), the Company is required to provide to the ASX, on a daily basis, disclosure of transactions pursuant to the Repurchase Program, if any. The Company also discloses information concerning the Repurchase Program in the Company's quarterly and annual reports. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.